Search Results
Test Catalog
BHISI - Overview: Bone Histomorphometry, Consultant Interpretation, Slides Only
Identifying undetermined metabolic bone disease in submitted slide specimens Diagnosing renal osteodystrophy Diagnosing osteomalacia Diagnosing osteoporosis Diagnosing Paget disease Assessing the effects of therapy Identifying...
ASHA - Overview: Arsenic, Hair
Detection of nonacute arsenic exposure in hair specimens
HPVLR - Overview: Human Papillomavirus (HPV) Low Risk, In Situ Hybridization
Detection of human papillomavirus from low-risk genotypes (6, 11)
RAT10 - Overview: Citrate/Creatinine Ratio, Urine
Calculating the citrate concentration per creatinine Diagnosing risk factors for patients with calcium kidney stones Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
UOSMS - Overview: Osmolality, Serum
Evaluating acutely ill or comatose patients
MYCON - Overview: Mycoplasma pneumoniae Antibody Interpretation
Interpretation for Mycoplasma pneumoniae screening results
23FBG - Overview: Fibroblast Growth Factor-23 (FGF23), In Situ Hybridization
Assessing fibroblast growth factor-23 (FGF23) expression
Detecting lead exposure using hair specimens
TMP - Overview: Trimethoprim, Serum
Monitoring trimethoprim therapy to ensure drug absorption, clearance, or compliance
SGUR - Overview: Specific Gravity, Random, Urine
As a partial assessment of the kidney's ability to concentrate urine
TAPEN - Overview: Tapentadol and Metabolite, Random, Urine
Monitoring of compliance utilizing tapentadol Detection and confirmation of the illicit use of tapentadol This test is not intended for use in employment-related testing.
URCON - Overview: Urea, Random, Urine
Assessment of kidney failure (prerenal vs acute kidney injury)
BARTB - Overview: Bartonella, Molecular Detection, PCR, Blood
Aiding in the diagnosis of Bartonella infection when Bartonella DNA would be expected to be present in blood, especially endocarditis
RCHLU - Overview: Chloride, Random, Urine
An indicator of fluid balance and acid-base homeostasis
CRTFR - Overview: Creatinine, Random, Urine
Normalizing urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
METR1 - Overview: Cytochrome b5 Reductase Enzyme Activity, Blood
Evaluation of patients with cyanosis Confirming cases of suspected cytochrome b5 reductase (methemoglobin reductase) deficiency Functional studies in families with cytochrome b5 reductase deficiency
LY27B - Overview: HLA-B27, Blood
Assisting in the diagnostic process of ankylosing spondylitis, juvenile rheumatoid arthritis, and reactive arthritis
HPVE6 - Overview: Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization
Stratification of oropharyngeal squamous cell carcinoma
HPVHL - Overview: Human Papillomavirus (HPV) High/Low Risk, In Situ Hybridization
Detecting human papillomavirus for both low-risk (6, 11) and high-risk (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.) genotypes
SUBIF - Overview: Immunoglobulin G (IgG) Subtypes Immunofluorescence, Tissue
Determining the subclass of IgG antibody found in renal immunofluorescent panel and determining if the deposits are monoclonal or monotypic
CRP - Overview: C-Reactive Protein (CRP), Serum
Detecting systemic inflammatory processes Detecting infection and assessing response to antibiotic treatment of bacterial infections Differentiating between active and inactive disease forms with concurrent infection
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
HICSF - Overview: Histoplasma Antibody Complement Fixation and Immunodiffusion, Spinal Fluid
Aiding in the diagnosis of Histoplasma meningitis using spinal fluid specimens
OLIGS - Overview: Oligoclonal Banding, Serum
Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings Determining number of serum oligoclonal bands in order to calculate the number of cerebrospinal fluid-specific...
NF4FS - Overview: Neurofascin-155 IgG4, Flow Cytometry, Serum
Evaluating patients with an underlying demyelinating neuropathy Diagnosis of a neurofascin-155 IgG4 mediated neuropathy
OLIGC - Overview: Oligoclonal Banding, Spinal Fluid
Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings
POU - Overview: Phosphorus, 24 Hour, Urine
Evaluation of hypo- or hyper-phosphatemic states Evaluation of patients with nephrolithiasis
TP - Overview: Protein, Total, Serum
Diagnosis and treatment of a variety of diseases involving the liver, kidney, or bone marrow, as well as other metabolic or nutritional disorders
PARVN - Overview: Parvovirus B19 Antibody, Technical Interpretation
Interpretation of serologic testing for recent or past parvovirus B19 infection This test is not useful as a screening procedure for the general population
EURO - Overview: Phospholipase A2 Receptor, Enzyme Linked Immunosorbent Assay, Serum
Distinguishing primary from secondary membranous nephropathy
PLA2M - Overview: Phospholipase A2 Receptor, Monitoring, Enzyme-Linked Immunosorbent Assay, Serum
Distinguishing primary from secondary membranous nephropathy Monitoring patients with membranous nephropathy, over time, for trends in anti-phospholipase A2 receptor antibody levels
PLA2I - Overview: Phospholipase A2 Receptor, Immunofluorescence, Serum
Distinguishing primary from secondary membranous nephropathy in patients with low levels of anti-phospholipase A2 receptor (PLA2R) antibodies Screening for anti-PLA2R antibodies Monitoring patients with membranous nephropathy at very...
RCVBS - Overview: Recoverin-IgG Antibody, Immunoblot, Serum
Evaluating patients with suspected paraneoplastic retinopathy accompanying small cell carcinoma
RTSC - Overview: Reptilase Time, Plasma
Evaluation of a prolonged thrombin time (TT): It is mainly used to confirm or exclude the presence of heparin in the specimen or specimen type Evaluating hypofibrinogenemia or dysfibrinogenemia in conjunction with the TT and fibrinogen...
PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...
DLAC - Overview: D-Lactate, Plasma
As an adjunct to urine D-lactate (preferred) for the diagnosis of D-lactate acidosis
CITR2 - Overview: Citrate Concentration, Random, Urine
Diagnosing risk factors for patients with calcium kidney stones Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
Interpretation for CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
CLDL1 - Overview: Cholesterol, Low-Density Lipoprotein (LDL), Calculated, Serum
Calculation of low-density lipoprotein cholesterol using total cholesterol, non-high-density lipoprotein (HDL) cholesterol, HDL cholesterol, and triglyceride concentrations Managing atherosclerotic cardiovascular disease risk
CRETR - Overview: Creatinine, Random, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
EHOLG - Overview: Entamoeba histolytica Antibody, Serum
As an adjunct in the diagnosis of extraintestinal, invasive amebiasis
EMAT - Overview: Endomysial Antibodies, IgA, Titer, Serum
Confirmation of a positive IgA-endomysial antibodies result
5BETH - Overview: Factor V Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against coagulation factor V
FENS - Overview: Fentanyl Screen, Random, Urine
Screening for drug abuse or use involving fentanyl
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases
LEIS - Overview: Leishmaniasis (Visceral) Antibody, Serum
Aiding in the diagnosis of active visceral leishmaniasis This test should not be used as the sole criteria for diagnosis.
KIPM - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Manual
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases, using a manual method
URCU - Overview: Uric Acid, 24 Hour, Urine
Assessment and management of patients with kidney stones, particularly uric acid stones
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
TOPI - Overview: Topiramate, Serum
Monitoring serum concentrations of topiramate Assessing compliance Assessing potential toxicity
Site Search
Week in Review: February 3 - Insights
Include: President Biden to End Covid-19 Emergencies On May 11, and Children’s Minnesota Received $3 Million Grant To Address Pediatric Health Disparities....
Top 3 reasons to join us at Leveraging the Laboratory 2025 - Insights
variety of perspectives pertaining to health system laboratory outreach programs. Here are the top 3 reasons why you should attend....
Leveraging the Laboratory Archives - Page 3 of 3 - Insights
Skip to Content MayoACCESS MayoLINK...
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Phlebotomy Modules: Module 3 | Insights
Skip to Content MayoACCESS MayoLINK...